Why we can have both innovative drugs and lower drug prices


13 October 2021 - The debate in Congress over negotiating drug prices is based on a phony premise that higher prices are needed to fund pharmaceutical R&D.

America is the undisputed global leader in drug research and development, and pharmaceutical companies warn that imposing controls on drug prices — like those currently being debated in Congress — will stifle that innovation. But many Americans, including the well insured, cannot afford the innovative drugs produced by that research.

Read Politico article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing , Innovation